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RNase L helps mediate the antiviral state induced by type I interferons (IFNαβ). Although herpes simplex virus (HSV) encodes inhibitors of the
IFNαβ-induced antiviral response, the IFNαβ system serves the body as a first line of defense against HSV.We investigated whether RNase L limits
HSV-2 replication and virulence. RNaseL−/− and wild-type C57BL/6 mice were infected intravaginally with HSV-2 strain 333. Although initial
replication in the genital epithelium was similar, mice lacking RNase L developed less severe genital and neurologic disease than wild-type mice,
survived longer, and contained lower viral titers in the nervous system. CD4+ T cell infiltration into the genital tract and spinal cord of RNase L−/−
mice was reduced, suggesting that a restricted inflammatory response may account for reduction in disease. Thus, RNase L does not play a significant
role in control of HSV-2 infection in vivo; instead, RNase L may regulate aspects of the inflammatory response that contribute to disease.
© 2006 Elsevier Inc. All rights reserved.Keywords: Herpes simplex virus; RNase L; Type I interferon; IFNαβ; Inflammation; GenitalIntroduction
The innate IFNαβ response exerts potent antiviral activity in
part by causing RNA degradation and translational arrest in
virus-infected cells to limit virus replication and spread. IFNαβ
are produced by most cells in response to virus infection, and
they initiate a signal transduction cascade by binding the IFNαβ
receptor (IFNαβR) on uninfected cells to stimulate transcription
of genes that prime for an antiviral state that is activated upon
virus infection. Among the many antiviral pathways induced by
IFNαβ, one prominent antiviral function is mediated by protein
kinase R (PKR), which phosphorylates eIF2α to arrest
translation. The oligoadenylate synthetase (OAS)/RNase L
pathway is another of the most extensively characterized.
IFNαβ signaling stimulates synthesis of OAS and RNase L
(Floyd-Smith, 1988), and once the cell is infected, viral double-⁎ Corresponding author. Fax: +1 314 977 8717.
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doi:10.1016/j.virol.2006.10.042stranded RNA (dsRNA) activates OAS to produce 2′5′-linked
oligoadenylates (2′5′A). The 2′5′A then activate RNase L to
degrade RNA, resulting in translation inhibition and blockade
of viral replication.
In vivo, herpes simplex virus (HSV) infections typically
initiate in a moist epithelial surface. Virus quickly spreads from
the epithelium into sensory nerves to establish latent infection.
Innate immune responses, particularly the IFNαβ response, are
essential during the first few days of infection to limit HSV
replication in the epithelium and spread into the nervous system.
In mouse models of HSV-1 ocular infection, neutralization of
IFNαβ results in a 1000-fold increase in titer of HSV-1 shed
from the cornea (Hendricks et al., 1991; Lausch et al., 1991).
Expression of IFNαβ in the cornea via plasmid DNA trans-
fection or adenovirus-mediated transduction limits replication
and enhances survival after corneal infection with HSV-1
(Noisakran et al., 1999; Al-khatib et al., 2004, 2005; Austin et
al., 2005). IFNαβ also have a protective role against HSV-1
infection in vitro, reducing viral immediately early (α) gene
expression (Klotzbucher et al., 1990; Mittnacht et al., 1988;
Oberman and Panet, 1988, 1989) and viral yield in fibroblasts
(Harle et al., 2002b; Noisakran et al., 2000; Harle et al., 2002a;
Fig. 1. Replication of HSV-2 in the genital mucosa of wild-type B6 and RNase
L−/− mice. Mice were infected i.vag. with 2×106 pfu/mouse of HSV-2 strain
333. (A) Titer of virus in vaginal swab samples taken 9 h to 4 days post-infection
was determined by standard plaque assay on Vero cells. Data points represent the
geometric mean±SEM for 6 mice per group in one of two experiments with
similar results.
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2003; Carr et al., 2003). The IFNαβ response is an important
component of host resistance during HSV-2 replication in the
genital epithelium, limiting virus spread to the lumbosacral
spinal cord and preventing neurologic disease (Murphy et al.,
2003). Expression of IFNα1 in the vaginal epithelium prior to
infection further reduces HSV-2 replication and virulence (Harle
et al., 2001).
Although the IFNαβ response intercedes in the early stages
of HSV-1 and HSV-2 infections, these neurotropic viruses have
developed resistance mechanisms to partially overcome its
effects. For example, HSV inhibits IFNαβ-induced antiviral
activities mediated by PKR through the actions of ICP34.5 and
Us11 (Cassady et al., 1998b; He et al., 1997). HSV-1 γ34.5 null
mutants are severely attenuated in wild-type mice, but restored
in PKR−/− mice (Leib et al., 2000), and the absence of ICP34.5
can be compensated by expression of Us11 as an immediate-
early gene (Cassady et al., 1998a). Furthermore, replication and
virulence of wild-type virus is not enhanced in the absence of
PKR (Harle et al., 2001; Leib et al., 2000), demonstrating that
HSV effectively blocks PKR-mediated antiviral activity using
these proteins. However, wild-type HSV replicates more readily
in mice that lack the IFNαβR (Murphy et al., 2003; Leib et al.,
1999), a finding which indicates the existence of additional
IFNαβ-induced antiviral pathways capable of suppressing
wild-type HSV growth in vivo.
Evidence has accumulated for the activity of the OAS/RNase
L pathway in protecting against HSV infection. In vitro, HSV-1
replicates to higher titers in RNase L−/− murine embryonic
fibroblasts (MEFs) and trigeminal ganglion neurons than in
wild-type cells (Harle et al., 2002b; Carr et al., 2003), suggesting
a role for RNase L in countering HSV infections. In vivo,
however, an antiviral function for RNase L remains controver-
sial. Studies supporting an antagonistic role have shown an
increase in replication of HSV-1 in the corneal epithelium of
RNase L−/− mice (Austin et al., 2005), and more severe ocular
disease and higher mortality (Zheng et al., 2002) compared to
wild-type mice. Yet contrasting results indicate that HSV-1
replication is not enhanced in the corneal epithelium (Leib et al.,
2000; Al-khatib et al., 2004) and trigeminal ganglia (Al-khatib et
al., 2004; Austin et al., 2005) of RNase L−/− mice, and neither is
overall virulence (Al-khatib et al., 2005). This lack of effect
could be explained by the purported induction by HSV-1 of 2′5′
A analogs that have diminished capacity to activate RNase L
(Cayley et al., 1984).
The role of the OAS/RNase L pathway in mediating IFNαβ-
induced protection against HSV-2 replication and spread is not
known. Although some data support a role for RNase L as an
HSV-1 antagonist, differences between HSV-1 and HSV-2 have
been found regarding their mechanisms of resistance to
mediators of IFNαβ-induced antiviral effects (Murphy et al.,
2003). Thus, the role of RNase L during HSV-2 genital infection
may differ from its role in protecting the cornea against
infection with HSV-1. We therefore investigated whether the
OAS/RNase L pathway influences host resistance to HSV-2 by
examining virus replication and disease induction during
primary genital infection of wild-type and RNase L−/− mice.Results
RNase L is a mediator of the IFNαβ response, and IFNαβ
plays an important role in the innate antiviral response against
HSV-2 in vivo (Murphy et al., 2003). To determine whether
RNase L contributes to host defense against primary HSV-2
infection, wild-type C57BL/6 and RNase L−/− mice were
infected by the intravaginal (i.vag.) route with 2×106 pfu/
mouse of HSV-2 strain 333. Titers of virus shed from the genital
epithelium and genital disease were assessed. 2′5′-OAS is
upregulated in the genital epithelium 24 h after HSV-2 infection
(Palliser et al., 2006). We therefore expected that if activated
RNase L mediates a vital antiviral response to HSV-2 in genital
epithelial cells, RNase L−/− mice would show prolonged virus
replication and more severe disease than wild-type mice.
However, replication of HSV-2 in the genital epithelium of
RNase L−/− and wild-type mice was similar at all time points
(Fig. 1). Thus it appears IFNαβ-stimulated pathways other than
those mediated by OAS/RNase L are important for controlling
HSV-2 replication in cells in the genital epithelium. Alter-
natively, HSV-2 may have evolved mechanisms that effectively
counteract RNase L-mediated antiviral responses in the genital
mucosa, thus neutralizing RNase L-mediated effects.
Surprisingly, despite virtually identical levels of virus repli-
cation in the epithelium, signs of genital disease developed more
slowly in RNase L−/− mice than in wild-type mice (Fig. 2A).
Inflammation of the external genitalia was less pronounced in
RNase L−/− mice than wild-type mice on Days 4 to 6 post-
infection (p<0.001). Genital lesions were present in 70% of
wild-type mice on Day 5 and in 100% on Day 6, but RNase L−/−
mice did not develop lesions until Day 6, when only 49% of the
mice were affected (p<0.0001 for Days 5 and 6). Signs of
neurologic disease were also greater in wild-type mice, with 61%
developing hind-limb paralysis by Day 6. In contrast, only 12%
of RNase L−/− mice became paralyzed (p<0.0001). Delayed
development of HSV-2-mediated disease in RNase L−/− mice
was reflected in their slower weight loss as infection progressed
(Fig. 2B; p≤0.0001 on Days 5 and 6 post-infection). Survival
Fig. 2. Severity of genital disease in wild-type B6 and RNase L−/− mice infected
with HSV-2. Mice were infected with 2×106 pfu/mouse i.vag. with HSV-2
strain 333. (A) Genital disease scores for 33 wild-type B6 and 43 RNase L−/−
mice; (B) change in weight for 22 wild-type B6 and 28 RNase L−/− mice were
recorded daily. Values represent the arithmetic mean±SEM. *p value <0.001;
**p value ≤0.0001.
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3). On Day 6, all RNase L−/− mice were alive, compared with
53% of wild-type mice (p=0.0003). On Day 7, 59% of RNase
L−/− mice were surviving, but only 21% of wild-type mice were
still alive (p=0.0252). Overall, the mean day of death for RNaseFig. 3. Survival time of mice after infection with a lethal dose of HSV-2. Wild-
type B6 and RNase L−/− mice were infected i.vag. with 2×106 pfu/mouse with
HSV-2 strain 333 and survival was recorded daily. n=19 for wild-type and
n=22 for RNase L−/− mice. **p value=0.0003 on Day 6; *p value=0.0252
on Day 7 post-infection.L−/− mice was 8.0±1.3, but wild-type mice succumbed by a
mean of 6.8±1.0 days post-infection (p=0.0021). These data
indicate similar kinetics of virus replication in the genital
epithelium but slower development of genital inflammation and
neurologic signs in mice lacking RNase L. The delayed onset of
inflammation and neurologic disease in RNase L−/− mice
corresponded with their slower demise.
Delayed development of neurologic signs and death in
RNase L−/− mice could be due to decreased virus replication in
the central nervous system (CNS), or to decreased inflammation
contributing to paralysis. To address these possibilities, we first
determined viral titer in the CNS of mice 6 days post-infection,
when neurologic signs were apparent. Virus titers in the spinal
cords of RNase L−/− mice were 3-fold lower than in wild-type
B6 mice (p=0.0152) and 6-fold lower in the brainstems
(p=0.0116; Fig. 4A). Thus, HSV-2 entered into or replicated in
the nervous systems of RNase L−/− mice less efficiently than
wild-type mice, despite replicating equally well in the genital
mucosae of both mouse strains. Direct intracranial injection of
virus revealed no difference in capacity of HSV-2 to replicate inFig. 4. Replication of HSV-2 in the neural tissues of wild-type B6 and RNase
L−/− mice. (A) Groups of mice surviving to Day 6 post-infection with HSV-2
were sacrificed, and brain, brainstem, and spinal cord tissues were dissected.
Viral titers in disrupted tissues were determined by plaque assay. The dashed
line indicates the limit of detection. n=13 for wild-type B6 mice and n=22
for RNase L−/− mice. *p value=0.0152; **p value=0.0116. (B) Groups of
mice were injected intracranially with 5×103 pfu of HSV-2 and sacrificed 1,
2 or 3 days post-infection. Brain tissue was removed and viral titers in
disrupted tissues were determined by plaque assay. Values represent the
geometric mean±SEM of 4 to 8 mice per group.
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suggesting that a difference in neuroinvasion rather than
neurovirulence accounted for the reduced titers of HSV-2 in
the spinal cords and brainstems of RNase L−/− mice.
We examined the additional possibility that a difference in
activation or recruitment of inflammatory infiltrates into
infected tissues resulted in less inflammation in RNase L−/−
mice and therefore reduced signs of disease. Six days post-
infection, vaginas and lumbosacral spinal cords were dissected,
subjected to collagenase digestion, and mononuclear cells were
isolated over Percoll gradients. Phenotypic staining followed by
flow cytometry revealed that: (i) Infiltration of mononuclear
cells in the vaginas and spinal cords increased markedly in all
infected mice relative to uninfected controls. (ii) The proportion
of activated (CD69+) cells among CD4+ and CD8+ T cells
infiltrating the vaginas and spinal cords of wild-type and RNase
L−/− mice was similar. (iii) The influx of CD8+ T cells into
tissues was relatively small, and the percentage (Fig. 5A) and
number (Fig. 5B) of CD45+CD8+ lymphocytes was higher in
the vaginas of infected RNase L−/− mice than wild-type mice
but not significantly different in the spinal cords. In contrast,
(iv) the percentage of CD45+CD4+ lymphocytes was lower in
both the vaginas and spinal cords of infected RNase L−/− mice
(Fig. 5C), and quantification of infiltrating CD4+ lymphocytesFig. 5. T lymphocyte infiltration into the genital tract and spinal cord. Groups of RN
6 days, genital tracts and lumbosacral spinal cords were dissected. Mononuclear cell
CD45-APC, anti-CD8-PE, anti-CD4-FITC, and anti-CD69-PerCP and analyzed by
typically associated with lymphocytes. Data from two individual experiments were p
T cells, respectively, recovered from 6 individual mice; (C and D) the mean number
*p value=0.0438.revealed similar trends (Fig. 5D). The latter observation
suggests that fewer CD4+ T cells had entered the infected
tissues in RNase L−/− mice than wild-type mice, and this
delayed the development of inflammation.
Discussion
Contrary to our expectation that HSV-2 would replicate more
readily and cause more disease in RNase L-deficient mice after
primary genital infection, we found that disease caused by HSV-
2 infection is milder in RNase L−/− mice than wild-type mice.
Viral replication, although similar in the vaginal epithelium, is
moderately lower in the nervous system of RNase L−/− mice.
Thus, RNase L is not necessary for resistance to primary HSV-2
infection in vivo, at least as assessed by genetic deletion.
Although the differences in viral titers in the spinal cords and
brainstems of RNase L−/− mice compared with wild-type mice
are modest, small reductions in virus replication in the CNS
may have profound effects on survival time, in that a threshold
may exist for causing paralytic or lethal neurologic disease.
Viral titers in the nervous systems of wild-type mice may have
reached this threshold more often and more quickly than in
RNase L−/− mice. Because a small number of wild-type mice
died before CNS tissues were collected for determination ofase L−/− or wild-type B6 mice were uninfected or infected with HSV-2. After
s enzymatically released from tissues of individual mice were stained with anti-
flow cytometry. Regions were defined by CD45+ cells of size and granularity
ooled and represented: (A and B) the mean percentage±SD of CD8+ and CD4+
of CD8+ and CD4+ T cells, respectively, recovered. **p value=0.0301–0.0379;
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observed (Fig. 4A) may underestimate the true magnitude of the
difference in replication of HSV-2 in the CNS of wild-type and
RNase L−/− mice on Day 6. We did not evaluate earlier time
points, and thus it is possible that titers in the spinal cords of
wild-type and RNase L−/− mice may be equivalent initially and
then gradually diverge.
Certain antiviral effector molecules such as RNase L may
play a more significant role in resistance to HSV infection if
upregulated by IFNαβ exposure prior to infection than they do
in the natural course of response to primary infection. Indeed,
IFNβ pretreatment suppresses HSV-1 replication in MEFs or in
cells derived from the trigeminal ganglia by a mechanism
requiring RNase L (Carr et al., 2003). Primary HSV-2 infection
of vaginal epithelial cells would be expected to stimulate some
IFNαβ to protect neighboring cells in advance of subsequent
rounds of virus replication. Thus, it would be predicted that
HSV should replicate more readily in RNase L-deficient mice.
Instead, replication is similar in the vaginal epithelium,
indicating that RNase L activity does not limit HSV-2
replication during primary genital infection of mice with
HSV-2. The role of RNase L may be usurped by other antiviral
mechanisms in the vaginal epithelial cells, creating no net
change in virus replication. In contrast to the vaginal epithelium,
virus titer in the spinal cord and brainstem of RNase L−/− mice
is modestly restricted, but how RNase L affects virus titer is
unclear. A subtle difference in genetic background between
wild-type and mutant mice cannot be ruled out but is unlikely to
be the sole cause of the disparity in titers. Reduced spinal cord
and brainstem titers after peripheral inoculation of virus may
result from differential neuroinvasion rather than neuroviru-
lence, as suggested by the observation that virus grows to
equivalent titers after direct introduction into the nervous
systems of RNase L−/− and wild-type mice. The lesser influx of
inflammatory cells into the spinal cords of RNase L−/− mice
may relate to neuroinvasion by delaying an increase in vascular
permeability or by restricting virus entry in association with
leukocytes trafficking into the tissue.
A surprising finding was the delayed development of severe
genital inflammation, genital lesions and paralysis in mice
lacking RNase L, suggesting that RNase L plays a potentiating
role in some aspects of HSV infection, whether directly or
indirectly. At least three possibilities may be entertained to
explain the mechanism underlying this observation. First,
disruption of a synergistic relationship between the ribonu-
clease activities of the virion host shutoff (vhs) protein and host
RNase L could explain the increased survival in RNase L−/−
mice. However, Northern blot analysis of GAPDH mRNA
revealed that mRNA degradation is equivalent in wild-type and
RNase L−/− MEFs infected with HSV-2 (data not shown), in
accord with previous observations with HSV-1 (Smith et al.,
2003). Second, HSV-mediated disease may appear less severe
in mice lacking RNase L because less apoptotic cell death
occurs in infected tissues. Cells derived from mice lacking
RNase L undergo apoptosis more slowly or show a deficiency
in apoptosis induction (Castelli et al., 1998; Zhou et al., 1998).
Apoptosis is not generally associated with erythema andedema, and thus an impact of RNase L on apoptotic cell
death probably does not explain decreased signs of genital
disease in HSV-2-infected RNase L−/− mice. However, this
hypothesis could pertain to a possible decrease or delay in
neuronal cell death, staving off paralysis and allowing longer
survival time.
Finally, there is evidence that RNase L plays a role in
modulating T cell responses in that RNase L−/− mice reject
tissue grafts more slowly than wild-type mice (Silverman et al.,
2002). T cells play important roles in host defense against
viruses but their activities also can contribute to immuno-
pathology. For example, IFNγ-producing CD4+ T cells have
been previously found in the genital tract after primary HSV-2
infection (Milligan and Bernstein, 1995) and may be important
for virus clearance (Milligan et al., 2004). However, their
activities may also contribute to genital inflammation asso-
ciated with HSV-2 infection (Harandi et al., 2001; Murphy
et al., 2003). Our finding that activated CD4+ T cells enter the
vaginal tracts of RNase L−/− mice less frequently than wild-
type mice is consistent with this interpretation. Reduced CD4+
T cell migration into vaginal tissue of RNase L−/− mice may
delay development of erythema and edema characteristic of the
inflammatory response to HSV-2. Similarly, subdued inflam-
matory influx into the spinal cords of HSV-2-infected RNase
L−/− mice may delay the onset of paralysis. CD4+ T cell influx
into the CNS consonant with virus infection (Marten et al.,
2001; Glass et al., 2005), and subsequent contribution to
pathology (Gerety et al., 1994; Lane et al., 2000; Rowell and
Griffin, 1999), has been observed in a number of virus-induced
CNS diseases. Thus, delaying the pathologic consequences of
an effector T cell response within the CNS could enhance the
life-prolonging effect of lower viral CNS titers in RNase L−/−
mice. A small reciprocal increase in the percentage of CD8+ T
cells infiltrating the genital tract of RNase L−/− mice was also
seen. HSV-specific CD8+ as well as CD4+ T cells have been
associated with immunopathology in the eye (Niemialtowski
and Rouse, 1992; Keadle et al., 2002; Osorio et al., 2004). It is
possible that CD8+ T cells also contribute to genital inflam-
mation, but this contribution is inapparent because CD8+ T
cells comprise a minor proportion of the tissue infiltrates.
Further experiments investigating inflammatory cytokine
production by T cells and/or apoptosis induction in the genital
epithelium and nervous system are needed to determine the




Vero cells were maintained in Dulbecco's modified Eagle's
medium supplemented with 3% newborn and 3% fetal calf
serum. SB5, a plaque-purified clone of HSV-2 strain 333, was
obtained from the American Type Culture Collection (VR-
2546). A cell lysate stock was prepared as previously described
(Morrison and Knipe, 1996). Titer of the virus stock was
determined by titration on Vero cell monolayers.
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RNase L−/− mice on the C57BL/6 background (Zhou et al.,
1997) were generously provided by Bob Silverman. Wild-type
C57BL/6 mice were purchased from the National Cancer
Institute (Fredericksburg, MD), the same source as previously
used by the Silverman laboratory (Silverman et al., 2002;
Leitner et al., 2003). RNase L−/− mice were bred and
maintained in the Department of Comparative Medicine, Saint
Louis University School of Medicine in accordance with
institutional and Public Health Service guidelines. Mice were
used at 6 weeks of age. Several experiments were performed
and the data from individual experiments were pooled.
Genital swab and neural tissue titers
Mice were infected by the i.vag. route with 2×106 pfu/
mouse as previously described (Morrison et al., 1998). Two
vaginal swabs per mouse were taken on Days 0–4 post-
infection using calcium alginate swabs (Puritan Medical
Products, Guiford, ME) which were placed together in vials
containing phosphate-buffered saline and stored at −80 °C. At 6
to 7 days post-infection, mice were sacrificed and the spinal
cord, brainstem, and brain were dissected. Alternatively, groups
of mice were inoculated intracranially with 5×103 pfu of HSV-
2 in 10 μl vol. using a 29-gauge insulin syringe (Terumo
Medical Corp., Somerset, NJ). Brain tissue was dissected 1, 2 or
3 days post-infection. Tissues were placed in microcentrifuge
tubes containing phosphate-buffered saline and 1-mm glass
beads, and stored at −80 °C. Thawed tissues were disrupted
using a Mini BeadBeater 8 (Biospec Products, Bartlesville,
OK). Viral titers were determined by standard plaque assay
(Knipe and Spang, 1982).
Disease scores
Severity of genital and neurologic disease was assessed on
Days 2 through 6 post-infection using the following scale: 0, no
signs; 1, mild erythema and edema of the external genitalia; 2,
moderate erythema and edema; 3, severe erythema and edema.
Flow cytometry
Genital tracts from the vaginal orifice to the exocervix and
lumbosacral spinal cords were dissected from wild-type and
RNase L−/− mice 6 days post-infection. Minced tissues were
digested in 1 ml of 1 mg/ml dispase/collagenase (Roche
Applied Sciences, Indianapolis, IN) for 40 min at 37 °C. Cells
released from genital tracts were incubated for 4 h at 37 °C in
12-well plates. Non-adherent cells were collected for staining.
Supernatants of spinal cord digests were layered over 30%–
70% discontinuous Percoll gradients (Redi-Grad, Amersham
Biosciences, Piscataway, NJ) and sedimented by centrifugation
at 2000 rpm for 20 min. Cells at the interface were collected and
washed before staining. Cells from individual mice were
incubated with FcBlock (BD PharMingen, San Diego, CA)
and then stained with a cocktail of anti-CD45-APC, anti-CD4-FITC, anti-CD8-PE, and anti-CD69-PerCP (BD PharMingen;
all used at a 1:150 dilution). Antibodies used to detect CD4 and
CD8 produce a mean fluorescence intensity shift of one decade
(10-fold) over a background of negative cells. Isotype controls
were used in initial experiments to verify authentic CD4 and
CD8 staining. Stained cells were subjected to 4-color flow
cytofluorometric analysis using a FACSAria (Becton Dick-
inson) and CellQuest analysis software.
Statistics
Significance of difference in viral titer between groups and
between percentage of CD4+ and CD8+cells in infiltrates was
determined by t test. The nonparametric Kruskall–Wallis test
was used to determine significance of difference in disease
scores between groups on individual days.
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